Loss Causation Theories

Loss Causation Under Dura: Corrective Disclosures vs. Materialized Risks

Both theories build on the same floor. Dura holds that "an inflated purchase price will not itself constitute or proximately cause the relevant economic loss," because "at the moment the transaction takes place, the plaintiff has suffered no loss; the inflated purchase payment is offset by ownership of a share that at that instant possesses equivalent value." The Court threw out the Ninth Circuit’s looser test — "To ‘touch upon’ a loss is not to cause a loss, and it is the latter that the law requires" — since the securities laws exist "not to provide investors with broad insurance against market losses, but to protect them against those economic losses that misrepresentations actually cause" Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (U.S. 2005). The PSLRA fixes who must prove it: plaintiffs carry "the burden of proving" that the misrepresentations "caused the loss for which the plaintiff seeks to recover."

On the corrective-disclosure pathway, the Eleventh Circuit just rejected the strictest reading. City of Hollywood Police Officers Retirement Syst v. NextEra Energy, Inc., et al, No. 24-13372 (11th Cir. Nov 26, 2025) held that "requiring a corrective disclosure to decisively and unequivocally debunk the earlier fraud overstates the role of loss causation—especially at the pleading stage." Instead, "the proper inquiry is whether enough truth has saturated the market to make investors second-guess the earlier fraud," and "[c]orrective disclosure[s] can come from any source and take any form from which the market can absorb [the information] and react." Gradual leakage counts: "a plaintiff need not rely on a single, complete corrective disclosure; rather, it is possible to show that the truth gradually leaked out into the marketplace ‘through a series of partial disclosures.’" And because loss causation "need not be pleaded with particularity" — Rule 8(a) governs, not Rule 9(b) — a court presented "with well-pleaded facts that the investing public related the corrective disclosure to the earlier misinformation" may not "substitute its own opinion on the matter." The panel reversed the dismissal.

The Second Circuit treats the labels as one requirement wearing two disguises. Puchtler v. Barclays PLC, No. 1:24-cv-01872 (S.D.N.Y. Mar 21, 2025) collected the framework: the circuit’s "past holdings do not suggest that ‘corrective disclosure’ and ‘materialization of risk’ create fundamentally different pathways for proving loss causation" — in a materialization case the disclosure simply "takes the form of an ‘event[] constructively disclosing the fraud’ instead of a clear statement correcting the prior misstatement." The plaintiff must show the loss was "foreseeable, that is, the ‘materialized risk that caused the loss was within the zone of risk concealed by the misrepresentations and omissions alleged by the disappointed investor.’" And "[i]n either event, it is the misrepresentations or omissions that must have caused the economic harm and not the event that is misrepresented" — so where the loss flowed from "the defendant’s exercise of a reserved right rather than the revelation of a concealed fact, the plaintiff inherently would have suffered the same harm and no Section 10(b) claim can stand." Barclays’ suspension of note issuances was such a reserved right; the complaint was dismissed with prejudice.

Pick the theory that matches the record. Gradual-leakage cases fit the corrective-disclosure pathway — plead each partial disclosure plus the market commentary tying it back to the misstatement, and resist demands for a single smoking-gun revelation. Concealed-condition cases fit materialization — plead the zone of risk and why the event that came to pass was its foreseeable realization. Under either label the same defects are fatal: a loss the defendant was always entitled to inflict, or a price drop untethered from anything the fraud actually concealed.